Ann Cramer is Director of Digital Product Delivery and Operations at LifeScan, a global leader in glucose monitoring and diabetes management. She is a results-driven leader with over 20 years of experience leading technology teams, providing custom proprietary and commercial solutions. Ms. Cramer has over 10 years of experience in regulated software development and has a passion for technological innovation and creating solutions that are engaging and support improvement of patient outcomes. Outside the office, Ms. Cramer keeps busy with her 4 children and 2 dogs. When possible, she loves entertaining her close friends and travel with her family.
Ilyssa Levins founded the Center for Communication Compliance (CCC) to help pharmaceutical and medical device companies save time and money, while managing risk. A 35+ year industry veteran, Ilyssa understands how to achieve both business and regulatory objectives, and align compliance and marketing stakeholders. An award-winning futurist, and published author, Ilyssa is on the cutting edge of applying artificial intelligence and natural language processing to manage the explosion of content that requires rapid review and approval to support the commercial’s strategy of customer centricity. Ilyssa was named one of the industry's 100 Inspiring People by PharmaVoice Magazine.
Anand Iyer is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in Welldoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. Since joining Welldoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. In 2013, Anand was named “Maryland Healthcare Innovator of the Year” in the field of mobile health. As a founding member of the Digital Therapeutics Alliance in November 2017, Anand works closely with the board to engage industry leaders on the integration of clinically-validated digital therapeutics to improve population health.